Ursolic Acid Reverses the Chemoresistance of Breast Cancer Cells to Paclitaxel by Targeting MiRNA-149-5p/MyD88

Paclitaxel (PTX) is widely used as a front-line chemotherapy for breast cancer treatment. However, its clinical applications are limited by the development of chemoresistance. The objective of this study was to investigate the reversal effects of ursolic acid (UA) on PTX resistance and the possible...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Xiang, Fenfen, Fan, Yan, Ni, Zhenhua, Liu, Qiaoli, Zhu, Zhaowei, Chen, Zixi, Hao, Wenbin, Yue, Honghong, Wu, Rong, Kang, Xiangdong
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587017/
https://ncbi.nlm.nih.gov/pubmed/31259152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00501
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados